Literature DB >> 12732839

"Inactive" excipients such as Cremophor can affect in vivo drug disposition.

Cristoph Wandel1, Richard B Kim, C Michael Stein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12732839     DOI: 10.1016/s0009-9236(03)00010-9

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  15 in total

1.  Generic and therapeutic substitution: a viewpoint on achieving best practice in Europe.

Authors:  Atholl Johnston; Roland Asmar; Björn Dahlöf; Kate Hill; David Albert Jones; Jens Jordan; Michael Livingston; Graham Macgregor; Michael Sobanja; Panagiotis Stafylas; Enrico Agabiti Rosei; José Zamorano
Journal:  Br J Clin Pharmacol       Date:  2011-11       Impact factor: 4.335

2.  The differences between the branded and generic medicines using solid dosage forms: In-vitro dissolution testing.

Authors:  Mubarak Nasser Al Ameri; Nanda Nayuni; K G Anil Kumar; David Perrett; Arthur Tucker; Atholl Johnston
Journal:  Results Pharma Sci       Date:  2011-12-07

3.  Development and optimization of solid self-nanoemulsifying drug delivery system (S-SNEDDS) using Scheffe's design for improvement of oral bioavailability of nelfinavir mesylate.

Authors:  Archita Patel; Pragna Shelat; Anita Lalwani
Journal:  Drug Deliv Transl Res       Date:  2014-04       Impact factor: 4.617

Review 4.  Clinical pharmacokinetics of docetaxel : recent developments.

Authors:  Sharyn D Baker; Alex Sparreboom; Jaap Verweij
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

5.  Commonly used excipients modulate UDP-glucuronosyltransferase 2b7 activity to improve nalbuphine oral bioavailability in humans.

Authors:  Hong-Jaan Wang; Cheng-Huei Hsiong; Shung-Tai Ho; Min-Jen Lin; Tung-Yuan Shih; Pei-Wei Huang; Oliver Yoa-Pu Hu
Journal:  Pharm Res       Date:  2014-02-14       Impact factor: 4.200

6.  Effectiveness, safety and cost of drug substitution in hypertension.

Authors:  Atholl Johnston; Panagiotis Stafylas; George S Stergiou
Journal:  Br J Clin Pharmacol       Date:  2010-09       Impact factor: 4.335

Review 7.  Potential clinical implications of substitution of generic cyclosporine formulations for cyclosporine microemulsion (Neoral) in transplant recipients.

Authors:  Atholl Johnston; Philip Belitsky; Ulrich Frei; John Horvath; Peter Hoyer; J Harold Helderman; Michael Oellerich; Stephen Pollard; Hany Riad; Paolo Rigotti; Paul Keown; Björn Nashan
Journal:  Eur J Clin Pharmacol       Date:  2004-06-17       Impact factor: 2.953

Review 8.  Characterising lipid lipolysis and its implication in lipid-based formulation development.

Authors:  Nicky Thomas; René Holm; Thomas Rades; Anette Müllertz
Journal:  AAPS J       Date:  2012-09-07       Impact factor: 4.009

9.  Cannabis constituents interact at the drug efflux pump BCRP to markedly increase plasma cannabidiolic acid concentrations.

Authors:  Lyndsey L Anderson; Maia G Etchart; Dilara Bahceci; Taliesin A Golembiewski; Jonathon C Arnold
Journal:  Sci Rep       Date:  2021-07-22       Impact factor: 4.379

10.  Formulation strategies for drug delivery of tacrolimus: An overview.

Authors:  Pranav Patel; Hitesh Patel; Shital Panchal; Tejal Mehta
Journal:  Int J Pharm Investig       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.